About Us
Company Profile
Executive Management
Board of Directors
Clinical Advisory Board
Our Pipeline
Our Science
For Patients
Investors & Media
Overview
News & Press Releases
Presentations
Publications
Events
SEC Filings
Stock Quote & Chart
Executive Management
Board of Directors
Board Committees
Corporate Governance
Clinical Advisory Board
Analyst Coverage
RSS Feeds
Contact Us
Contact Us
About Us
Company Profile
Executive Management
Board of Directors
Clinical Advisory Board
Our Pipeline
Our Science
For Patients
Investors & Media
Overview
News & Press Releases
Presentations
Publications
Events
SEC Filings
Stock Quote & Chart
Executive Management
Board of Directors
Board Committees
Corporate Governance
Clinical Advisory Board
Analyst Coverage
RSS Feeds
Contact Us
Contact Us
Home
>
News
All
|
News
|
Press Release
|
Events
Jodi’s Journal: The Little Biotech Company That Could Beat COVID-19
April 26, 2020
Behind SAB’s Rapid Response To COVID-19
April 24, 2020
SAB Biotherapeutics Advances Therapeutic For COVID-19 In Partnership With Department Of Defense And BARDA
April 16, 2020
HHS Facilitates Development Of Immunotherapies For COVID-19 Patients
April 13, 2020
CSL Behring And SAB Biotherapeutics Join Forces To Deliver New Potential COVID-19 Therapeutic
April 8, 2020
BARDA, Department Of Defense, And SAb Biotherapeutics To Partner To Develop A Novel COVID-19 Therapeutic
April 2, 2020
SAB Biotherapeutics Awarded $27M Contract to Develop Novel Rapid Response Capability for U.S. Department of Defense
March 31, 2020
SAB Biotherapeutics Delays Development At USD Discovery District
March 13, 2020
Sioux Falls Biotech Firm Rushing To Develop Coronavirus Treatment
March 12, 2020
Personal Impact, Global Influence, Right Here In South Dakota
February 18, 2020
SAB Biotherapeutics Announces Research Collaboration With CSL Behring
January 7, 2020
South Dakota Leads The Future Of Fighting Disease
December 13, 2019
Previous
Next